4.7 Review

Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection

Journal

Publisher

MDPI
DOI: 10.3390/ijms18081717

Keywords

respiratory syncytial virus; genotype; children; lower respiratory tract infections; bronchiolitis; monoclonal antibodies; vaccines

Ask authors/readers for more resources

Respiratory syncytial virus (RSV) belongs to the recently defined Pneumoviridae family, Orthopneumovirus genus. It is the leading cause of acute bronchiolitis and one of the most common causes of infant viral death worldwide, with infection typically occurring as recurrent seasonal epidemics. There are two major RSV subtypes, A and B, and multiple genotypes, which can coexist during RSV epidemic season every year and result in different disease severity. Recently, new RSV genomic sequences and analysis of RSV genotypes have provided important data for understanding RSV pathogenesis. Novel RSV strains do spread rapidly and widely, and a knowledge of viral strain-specific phenotypes may be important in order to include the more virulent strains in future therapeutical options and vaccine development. Here we summarize recent literature exploring genetic and molecular aspects related to RSV infection, their impact on the clinical course of the disease and their potential utility in the development of safe and effective preventive and therapeutic strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pediatrics

Carditis in Acute Rheumatic Fever in a High-Income and Moderate-Risk Country

Marianna Fabi, Margherita Calicchia, Angela Miniaci, Anna Balducci, Elena Tronconi, Simone Bonetti, Ilaria Frabboni, Carlotta Biagi, Gabriele Bronzetti, Andrea Pession, Andrea Donti, Marcello Lanari

JOURNAL OF PEDIATRICS (2019)

Review Pediatrics

Single-dose of ondansetron for vomiting in children and adolescents with acute gastroenteritis-an updated systematic review and meta-analysis

Francesco Fugetto, Emanuele Filice, Carlotta Biagi, Luca Pierantoni, Davide Gori, Marcello Lanari

EUROPEAN JOURNAL OF PEDIATRICS (2020)

Review Microbiology

Rhinovirus Infection in Children with Acute Bronchiolitis and Its Impact on Recurrent Wheezing and Asthma Development

Carlotta Biagi, Alessandro Rocca, Giulia Poletti, Marianna Fabi, Marcello Lanari

MICROORGANISMS (2020)

Letter Allergy

Insights into Mycoplasma-associated mucocutaneous disease

Arianna Dondi, Ambra Di Altobrando, Roberta Parladori, Carlotta Biagi, Annalisa Patrizi, Marcello Lanari, Iria Neri

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Review Biochemistry & Molecular Biology

Passive Immunoprophylaxis against Respiratory Syncytial Virus in Children: Where Are We Now?

Alessandro Rocca, Carlotta Biagi, Sara Scarpini, Arianna Dondi, Silvia Vandini, Luca Pierantoni, Marcello Lanari

Summary: Respiratory syncytial virus (RSV) is the main cause of acute respiratory tract infections in children worldwide, and while only symptomatic treatment is available, passive immune prevention methods are being developed for all infants. The high cost of passive immunoprophylaxis limits its prescription to high-risk children, though most hospitalized RSV-infected children do not fully meet the criteria for immune prophylaxis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Virology

Potential Diagnostic and Prognostic Biomarkers for Adenovirus Respiratory Infection in Children and Young Adults

Giovanni Battista Biserni, Sara Scarpini, Arianna Dondi, Carlotta Biagi, Luca Pierantoni, Riccardo Masetti, Sugitha Sureshkumar, Alessandro Rocca, Marcello Lanari

Summary: HAdV infections can lead to strong inflammatory responses and high morbidity. Diagnostic tools include rapid antigen detection kits and rapid molecular diagnosis, but costs and feasibility limit their use in hospitals. The aim of the study is to evaluate whether markers based on host response can help in early identification of HAdV and prevent inappropriate antibiotic use.

VIRUSES-BASEL (2021)

Review Immunology

Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice

Sara Scarpini, Francesca Morigi, Ludovica Betti, Arianna Dondi, Carlotta Biagi, Marcello Lanari

Summary: hCMV is a common cause of congenital infection, leading to potential permanent impairment and severe disease in immunocompromised individuals. Research on hCMV vaccines is ongoing, but challenges in development include the virus's ability to evade immune response and identifying target populations for vaccination.

VACCINES (2021)

Article Pediatrics

Three-Year Trend in Escherichia coli Antimicrobial Resistance among Children's Urine Cultures in an Italian Metropolitan Area

Luca Pierantoni, Laura Andreozzi, Simone Ambretti, Arianna Dondi, Carlotta Biagi, Francesco Baccelli, Marcello Lanari

Summary: Urinary tract infections (UTIs) are common in children, with Escherichia coli being the main pathogen. While Italian guidelines recommend amoxicillin-clavulanic acid (AMC) as a first-line therapy for febrile UTIs in children, a study in northern Italy found an increasing resistance rate of E. coli to AMC over a three-year period. This calls into question the use of AMC as the first-line therapy for pediatric UTIs in this population.

CHILDREN-BASEL (2021)

Article Pediatrics

Impact of SARS-CoV-2 Pandemic on Bronchiolitis Hospitalizations: The Experience of an Italian Tertiary Center

Giacomo Stera, Luca Pierantoni, Riccardo Masetti, Davide Leardini, Carlotta Biagi, Danilo Buonsenso, Andrea Pession, Marcello Lanari

Summary: The study found a significant decrease in hospitalizations for bronchiolitis at the center throughout the entire SARS-CoV-2 outbreak, rather than just during lockdown periods. This suggests a crucial role for cost-effective non-pharmaceutical interventions (NPIs) such as mandatory face masks and hand hygiene measures in reducing the spread of infectious agents during the pandemic.

CHILDREN-BASEL (2021)

Article Emergency Medicine

Subcutaneous emphysema of the neck as a complication of high flow therapy in children: A case report

Luca Pierantoni, Arianna Dondi, Carlotta Biagi, Andrea Scozzarella, Federica Camela, MArcello Lanari

Summary: High Flow Nasal Cannula (HFNC) is a noninvasive technique increasingly used in pediatric wards for respiratory support. However, patients undergoing HFNC should be strictly monitored to promptly recognize and treat complications such as pneumomediastinum.

EMERGENCY CARE JOURNAL (2021)

Article Virology

Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area

Marianna Fabi, Emanuele Filice, Carlotta Biagi, Laura Andreozzi, Daniela Palleri, Bianca Elisa Mattesini, Alessia Rizzello, Liliana Gabrielli, Chiara Ghizzi, Daniela Di Luca, Fabio Caramelli, Alessandro De Fanti, Marcello Lanari

Summary: This study investigated children with Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease (KD), revealing that MIS-C patients exhibit more severe cardiac injury at disease onset and a faster response to immunomodulatory treatment, while some KD patients still have persistent cardiac anomalies after treatment.

VIRUSES-BASEL (2021)

Article Microbiology

Impact of Guidelines Publication on Acute Bronchiolitis Management: 10-Year Experience from a Tertiary Care Center in Italy

Carlotta Biagi, Sara Scarpini, Camilla Paleari, Marianna Fabi, Arianna Dondi, Liliana Gabrielli, Monia Gennari, Marcello Lanari, Luca Pierantoni

Summary: By comparing the management of bronchiolitis in infants over the past ten years in a Tertiary Care Center in Italy, it was found that adherence to national guidelines has improved in terms of reducing prescriptions for systemic corticosteroids, nebulized epinephrine, antibiotics, and chest X-rays. However, further efforts are needed to limit the use of ineffective therapies like antibiotics and inhaled salbutamol.

MICROORGANISMS (2021)

Article Microbiology

Pulmonary and Extrapulmonary Manifestations in Hospitalized Children with Mycoplasma Pneumoniae Infection

Carlotta Biagi, Alessandra Cavallo, Alessandro Rocca, Luca Pierantoni, Davide Antonazzo, Arianna Dondi, Liliana Gabrielli, Tiziana Lazzarotto, Marcello Lanari

Summary: Mycoplasma pneumoniae is a common cause of respiratory infections in school-aged children, and can also lead to extrapulmonary manifestations. This study conducted a retrospective analysis of MP-positive pediatric patients admitted to a hospital in Northern Italy, revealing a high incidence of MP infection among hospitalized children and varied clinical presentations across different age groups, including extrapulmonary symptoms.

MICROORGANISMS (2021)

Article Medicine, General & Internal

Prognostic Role of Lung Ultrasound in Children with Bronchiolitis: Multicentric Prospective Study

Laura Gori, Antonella Amendolea, Danilo Buonsenso, Stefano Salvadori, Maria Chiara Supino, Anna Maria Musolino, Paolo Adamoli, Alfina Domenica Coco, Gian Luca Trobia, Carlotta Biagi, Marco Lucherini, Alberto Leonardi, Giuseppe Limoli, Matteo Giampietri, Tiziana Virginia Sciacca, Rosa Morello, Francesco Tursi, Gino Soldati

Summary: This study aimed to evaluate a qualitative and quantitative lung ultrasound (LUS) protocol for the diagnosis and follow-up of bronchiolitis. The results showed that LUS can help assess the severity of bronchiolitis and provide information on changes in lung aeration during follow-up.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Immunology

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines

Carlotta Biagi, Arianna Dondi, Sara Scarpini, Alessandro Rocca, Silvia Vandini, Giulia Poletti, Marcello Lanari

VACCINES (2020)

No Data Available